
Oncology NEWS International
- Oncology NEWS International Vol 11 No 5
- Volume 11
- Issue 5
Total US AIDS Deaths Top 440,000, With Up to 950,000 HIV Infected
WASHINGTON-AIDS deaths in the United States total more than 440,000 since 1981, according to a new Department of Health and Human Services (HHS) fact sheet. The number of HIV-infected Americans now stands at an estimated 850,000 to 950,000, one quarter of whom do not know they carry the virus.
WASHINGTONAIDS deaths in the United States total more than 440,000 since 1981, according to a new Department of Health and Human Services (HHS) fact sheet. The number of HIV-infected Americans now stands at an estimated 850,000 to 950,000, one quarter of whom do not know they carry the virus.
Nonetheless, HHS said, significant progress has been made against the AIDS epidemic in the 2 decades since it began. AIDS infections dropped from a peak of roughly 150,000 a year to some 40,000 annually by the early 1990s. Mother-to-child HIV infection has declined from 2,500 in 1992 to 300 to 400 annually in recent years.
Articles in this issue
about 24 years ago
Prognosis Good for Local Recurrence After Lumpectomyabout 24 years ago
Long-Term Use of Actiq Safe and Effective for Breakthrough Painabout 24 years ago
Youth Exposed to Tobacco Promotionsabout 24 years ago
Green Tea May Help Prevent Certain Gastrointestinal Cancersabout 24 years ago
EGFR Inhibitor Effective as Salvage Therapy for NSCLCabout 24 years ago
Targeted Filgrastim Support Allows Planned Chemotherapy Dosesabout 24 years ago
Low Risk of CHF With Paclitaxel/Trastuzumab Adjuvant Rxabout 24 years ago
Anxiety, Depression in Women at High Risk for Breast Cancerabout 24 years ago
NCCN Updates its Treatment Guidelines for Breast Cancerabout 24 years ago
Danny Glover ‘Acting’ as Spokesman for Anemia LifeLineRelated Content


109 Extended Adjuvant Neratinib in HER2+/HR+ Early Breast Cancer in Clinical Routine: Final Results from the Multi-national, Prospective, Observational Study ELEANOR

110 Randomized Phase II Trial Evaluating Three Anti-diarrheal Prophylaxis Strategies in Patients (pts) with HER2+/HR+ Early Breast Cancer (EBC) Treated with Extended Adjuvant Neratinib (Dianer Geicam/2018-06)




















